News
Moderna’s New Flu Shot Shows Strong Results in Older Adults
The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA. Copyright © 2025 HealthDay. All rights reserved.
Moderna’s new flu vaccine shows positive results in elderly individuals
Moderna’s latest flu vaccine, based on similar mRNA technology integrated in its COVID-19 shot, displayed optimistic outcomes in a significant trial.On Monday, the company revealed that the vaccine, which is known as mRNA-1010,
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...
Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy ...
The Moderna vaccine can be efficient at protecting individuals and people around them from COVID-19. Learn more about it here.
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
Stocktwits on MSN5d
Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine SkepticsRetail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback